Clinical Cancer Research · 2012 · 243 citations · 36 references
Our findings provide a proof-of-principle that formulated synthetic miR-34a has therapeutic activity in preclinical models and support a framework for development of miR-34a-based treatment strategies in MM patients.
36
Most mammalian mRNAs are conserved targets of microRNAs
Robin C. Friedman, Kyle Kai‐How Farh, Christopher B. Burge et al. · Genome Research · 2008 · 8.4K citations · Full text
A microRNA component of the p53 tumour suppressor network
Lin He, Xingyue He, Lee P. Lim et al. · Nature · 2007 · 2.7K citations · Full text